Clinical Trial Update: Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine therapy in breast cancer patients receiving trastuzumab for HER2-positive disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• Vaccine therapy

Snippet

Sponsor: University of Washington | Conditions: HER2-positive Breast Cancer, Male Breast Cancer | Phase 2 | Status: COMPLETED